Evidence map›Paper›PMID 32214229›Full record

Trial reportBone marrow transplantation2020

A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients.

Barbara Jeker, Sarah Farag, Behrouz Mansouri Taleghani, Urban Novak, Beatrice U Mueller, Qiyu Li, Daniel Betticher, Jean-Marc Luethi, Simone Farese, Axel Ruefer and 2 more

Abstract readLetterRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Barbara JekerDepartment of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
Sarah FaragDepartment of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
Behrouz Mansouri TaleghaniDepartment of Hematology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
Urban NovakDepartment of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
Beatrice U MuellerDepartment of Clinical Research, University of Bern, Bern, Switzerland.
Qiyu LiSAKK Coordinating Centre, Bern, Switzerland.
Daniel BetticherDepartment of Oncology, Kantonsspital, Fribourg, Switzerland.
Jean-Marc LuethiDepartment of Oncology, Regionalspital, Thun, Switzerland.
Simone FareseDepartment of Oncology, Kantonsspital, Solothurn, Switzerland.
Axel RueferDepartment of Hematology, Kantonsspital, Lucerne, Switzerland.
Ulrike Bacher *Department of Hematology, Inselspital, University Hospital and University of Bern, Bern, Switzerland.
Thomas Pabst *Department of Medical Oncology, Inselspital, University Hospital and University of Bern, Bern, Switzerland. thomas.pabst@insel.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell MobilizationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsDeoxycytidineGemcitabineHumansStem CellsVinorelbineDeoxycytidineGemcitabineVinorelbine

Identifiers

PMID32214229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.